@Article{,
AUTHOR = {Bryce A. Baird, Timothy D. Lyon, Kevin Wu, Augustus Anderson, Gregory A. Broderick},
TITLE = {Complete pathologic response of bulbar  urethral squamous cell carcinoma in situ to  topical 5-fluorouracil with urethral milking},
JOURNAL = {Canadian Journal of Urology},
VOLUME = {29},
YEAR = {2022},
NUMBER = {2},
PAGES = {11119--11122},
URL = {http://www.techscience.com/CJU/v29n2/59979},
ISSN = {1488-5581},
ABSTRACT = {Primary urethral carcinoma is a rare oncologic condition with limited data to support organ-sparing therapies. Herein, we present a case of primary urethral squamous cell carcinoma in situ of the bulbar urethra treated with intraurethral 5-fluorouracil (5-FU) who exhibited a complete pathologic response observed at the time of dismembered urethroplasty. The clinical features, diagnosis, and treatment course of our case are reviewed.  These data may support the use of intraurethral 5-FU for similar cases in the future.},
DOI = {}
}